Abstraction Health

Fish Oil / Omega-3 vs Vitamin D

Both are commonly discussed for focus & cognition and mood and inflammation and energy and immune health. Fish Oil / Omega-3 and Vitamin D both have moderate evidence — Vitamin D edges ahead on research volume (20 vs 20 studies referenced).

Evidence last reviewed May 2026

Fish Oil / Omega-3 recommends stacking with Vitamin D: Both are fat-soluble and support cardiovascular, immune, and neurological health; co-administration with a fatty meal enhances absorption of both.

Fish Oil / Omega-3
Essential Fatty Acid
Vitamin D
Fat-Soluble Vitamin
Evidence
🟡Moderate Evidence
🟡Moderate Evidence
Research says
Partially supported
Partially supported
Expert mentions
181
4 recommend
245
3 recommend
Studies
20
referenced
20
referenced
Study dose
1000–4000mg
Studies across the reviewed literature examined doses ranging from approximately 1,000 mg to 4,000 mg of combined EPA+DHA per day; expert commentary (Huberman) highlights doses above 1 g EPA/day for mood effects and 2–4 g/day for triglyceride reduction, though optimal doses vary by condition and individual.
Best timing
MorningWith food
MorningWith food
Who recommends
Gary Brecka
Andrew Huberman
Mark Hyman
David Sinclair
Rhonda Patrick
Gary Brecka
Mark Hyman
Caution
Generally safe
Generally safe

Fish Oil / Omega-3

Key findings
  • ·Multiple strong-quality meta-analyses and systematic reviews suggest fish oil supplementation may improve blood lipid profiles (particularly triglycerides) in people with hyperlipidemia, and may reduce arterial stiffness based on randomized controlled trial data.
  • ·Omega-3 supplementation has been investigated for PCOS, with systematic reviews and umbrella reviews of meta-analyses examining effects on metabolic and endocrine outcomes, though the strength and consistency of benefit varies across endpoints.
  • ·A Mediterranean-style dietary intervention supplemented with fish oil showed promising signals for mental health improvement in people with depression, though this was a single moderate-quality RCT and conclusions should be drawn cautiously.
Evidence gaps
  • ·Most individual studies in this set do not report specific population characteristics or sample sizes in the available metadata, making it difficult to determine which populations benefit most and whether findings generalize broadly.
  • ·The majority of expert claims assessed (135 out of 169) were rated as having insufficient evidence, suggesting that many specific claims made about fish oil — including highly specific therapeutic applications — outpace what the current research can confidently support.
Full profile →

Vitamin D

Key findings
  • ·A strong-quality meta-analysis supports combined calcium and vitamin D supplementation for reducing osteoporosis risk in postmenopausal women.
  • ·A single moderate-quality RCT (D-Health trial) found limited evidence that vitamin D supplementation significantly reduces major cardiovascular events.
  • ·One moderate-quality RCT found vitamin D supplementation was associated with higher testosterone levels in men, but this has not been sufficiently replicated.
Evidence gaps
  • ·No studies in this review directly tested health outcomes at the specific serum vitamin D range of 60–80 ng/mL, leaving expert claims about optimal target levels unsupported by the current evidence base.
  • ·The testosterone finding comes from a single moderate-quality RCT; additional well-powered replication trials are needed before this can be considered an established benefit.
Full profile →
Compare other supplements